EXECUTIVE ENGAGEMENTS
POOL
3881
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
699
Interactions with Platform & by Email
PARTICIPANTS
116
Unique # Participated
VALIDATIONS
34
Responses Validated*
COMPANIES
116
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
202
PAGES
312
EDITION
18
PRICE
USD 5450
CODE
MCP-6052
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Immunochemicals estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at aCAGR of 5.3% over the period 2020-2027. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The Immunochemicals market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$929.7 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
SELECT PLAYERS
Abcam Plc.; Agilent Research Laboratories; Beckman Coulter GmbH; Biolegend Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; GenScript Biotech Corporation; PerkinElmer Inc.; Rockland Immunochemicals Inc.; Santa Cruz Biotechnology Inc.; Sigma-Aldrich Corporation; Thermo Fischer Scientific Inc.
SEGMENTS
» Type (Catalog Antibodies, Custom Antibodies)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Immunochemicals - A Prelude |
| Recent Market Activity |
| Research Antibodies Market: Critical Role in Drug Discovery and Research |
| Key Factors Influencing Purchasing Decisions |
| Citations: One of the Key Factors Driving Research Antibodies’ Purchase |
| The US Dominates the Global Immunochemicals Market |
| Emerging Markets Offer Huge Potential |
| Catalog Antibodies - The Largest Market Segment |
| Custom Antibodies: Finding Favor in Research Applications |
| Primary Antibodies Dominate the Market |
| Competitive Scenario |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abcam Plc. (UK) |
| Agilent Research Laboratories (USA) |
| Biolegend, Inc. (USA) |
| Bio-Rad Laboratories, Inc. (USA) |
| Cell Signaling Technology, Inc. (USA) |
| GenScript Biotech Corporation |
| PerkinElmer, Inc. (USA) |
| Rockland Immunochemicals, Inc. (USA) |
| Santa Cruz Biotechnology, Inc. (USA) |
| Merck (Sigma-Aldrich Corporation) (USA) |
| Thermo Fisher Scientific Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Research Funding Bolsters Market Growth |
| Chinese Market to Become the Largest Investor in Basic Research |
| Cancer Research Drives the Global Immunochemicals Market |
| Cancer Ranks Among the Top Ten Causes of Death Worldwide |
| ‘Reproducibility Crisis’ of Antibodies - A Major Cause of Concern |
| Proper Validation of Antibodies - Vendor Do their Part |
| New Technologies for Antibodies Validation |
| Personalized Medicine Offers New Growth Avenues |
| Rabbit Monoclonal Antibodies Score over Other Animal Antibodies |
| Researchers Prefer Commercial Research to Academic Research |
| Increasing Collaborations between Industry and Academia |
| Beckman Coulter GmbH (USA) |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 116 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com